Aerie Pharmaceuticals
World Rank (Jan-05-2024)
15,308
World Rank (Jul-30-2023)
15,308
World Rank (Dec-25-2022)
15,308
World Rank (Jan-07-2022)
15,308
Market Cap (Jan-07-2022)
0.37 Billion USD
Annual Revenue in USD
83 Million USD
Annual Net Income in USD
-183 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Company Profile
Aerie Pharmaceuticals is a Ophthalmic Pharmaceuticals company. It focused on the discovery, development and commercialization of first in class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye. The company annual revenue is 20.1 million USD and 353 employees as on 2020. The headquarters is in USA.
Company Website